Compartmental Model for 223 Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.

MLA

Taprogge, Jan, et al. “Compartmental Model for 223 Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 105, no. 4, Nov. 2019, pp. 884–92. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2019.07.022.

APA

Taprogge, J., Murray, I., Gear, J., Chittenden, S. J., Parker, C. C., & Flux, G. D. (2019). Compartmental Model for 223 Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer. International Journal of Radiation Oncology, Biology, Physics, 105(4), 884–892. https://doi.org/10.1016/j.ijrobp.2019.07.022

Chicago

Taprogge, Jan, Iain Murray, Jonathan Gear, Sarah J Chittenden, Christopher C Parker, and Glenn D Flux. 2019. “Compartmental Model for 223 Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer.” International Journal of Radiation Oncology, Biology, Physics 105 (4): 884–92. doi:10.1016/j.ijrobp.2019.07.022.